| COVID-19 convalescent plasma as long-term therapy in immunodeficient patients? D Rnjak, S Ravlić, AM Šola, B Halassy, J Šemnički, M Šuperba, ... Transfusion Clinique et Biologique 28 (3), 264-270, 2021 | 29 | 2021 |
| Biomarkers in different asthma phenotypes S Popović-Grle, A Štajduhar, M Lampalo, D Rnjak Genes 12 (6), 801, 2021 | 24 | 2021 |
| Is better standardization of therapeutic antibody quality in emerging diseases epidemics possible? S Ravlić, A Hećimović, T Kurtović, JI Jelečki, D Forčić, A Slović, IC Kurolt, ... Frontiers in immunology 13, 2022 | 4 | 2022 |
| COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits T Vuk, A Hećimović, I Jukić, S Ravlić, T Kurtović, D Rnjak, B Halassy Transfusion Clinique et Biologique 28 (4), 424, 2021 | 1 | 2021 |
| Which came first, allergic bronchopulmonary aspergillosis or asthma? D Rnjak, A Štajduhar, M Lampalo, J Rnjak, M Gracin, S Popović-Grle J Clin Images Med Case Rep 3 (2), 1692, 2022 | | 2022 |
| Does Smoking Status Impact the Severity of Acute COVID-19? D Rnjak, L Basara, M Banić, D Baričević, F Džubur, A Hećimović, ... Psychiatria Danubina 33 (2), 252-253, 2021 | | 2021 |
| Koinfekcija pluća s Mycobacterium tuberculosis i Nocardia spp. kod bolesnika s transplantiranim plućima D Rnjak, F Džubur, J Knežević, G Pavliša, A Hećimović, G Glodić, ... Infektološki glasnik 41 (3), 104-107, 2021 | | 2021 |
| A Case of Pulmonary Co-Infection by Mycobacterium Tuberculosis and Nocardia spp. in a Lung Transplant Recipient D Rnjak, F Džubur, J Knežević, G Pavliša, A Hećimović, G Glodić, ... transplantation 5, 6, 2021 | | 2021 |
| Skin and lung tuberculosis in patients with mixed connective disease-case report A Petrović Vlahović, M Nakić, D Rnjak, AM Šola, V Vrčić, M Vrčić Medica Jadertina 49 (2), 129-134, 2019 | | 2019 |
| Kožna i plućna tuberkuloza u bolesnice s miješanom bolesti vezivnoga tkiva-prikaz bolesnice A Petrović Vlahović, M Nakić, D Rnjak, AM Šola, V Vrčić, M Vrčić Medica Jadertina 49 (2), 129-134, 2019 | | 2019 |
| Sars-Cov-2 Neutralization Assay–Reliable Tool for Assessing Therapeutic Antibody Quality D Forčić, S Ravlić, A Hećimović, T Kurtović, J Ivančić Jelečki, ... | | |
